Is he continuing to sell stock? I just googled it and articles from May 4th came up.
Yeah. Huge short hit job by Citron based on CEO ‘s bad very disturbing past, but not about anything he has done in the last few months. He sold his warrants to make a mandatory payment to Samsung in late April. Stock just started climbing last 7 days , so he hasn’t sold stock while it was going up. Samsung , who they contracted with to ramp up production of Leronlimab if FDA gives approval was absolutely necessary . He didn’t dilute shareholder value. His past is hideous and damning but his hires of Dr. Jacob Lazelari, a respected doctor as their medical director, and teaming with Dr. Bruce Patterson , CEO of Incelldx, the company that does the diagnostics on levels of Covid patients, who has authored a manuscript that describes Covid as a Rantes disease and that Leronlimab blocks the cytokines storm, reduces the viral load and brings the immune system to homeostasis allowing it to fight the virus, are good things for the company . His paper has been submitted to the New England Journal of Medicine and is being peer reviewed now. There has been no news except the 2 FDA trials for mild/ moderate and severe/ critical patients will have their results and interim results released soon. Company announced a deal with Mexico yesterday to do a Phase 3 trial for severe/ critical patients , which is more positive news. Otherwise, there has been no other news lately( last month) . This was nothing more than a classic short hit job and it worked. Good opportunity to buy some more.
It was tried by Adam Feuerstein in early May and failed. Short selling hit job . Stock hovered around $2.50 , but most investors took it as a hit job.
Will know soon. Cintron did the same thing to Inivio 6 months ago. Stock went to $20 and hit piece comes out and stock goes to $6. It has recovered and now $26. Hope the same happens to Cytodyn .
I have to admit this stock peaked my interest and I had thoughts of putting a few chips on the roulette wheel but nothing like I did another stock years ago , you know the next big thing , back then it was the next gatorade and I lost my shirt, anyway I learned my lesson and followed my gut. Seems something may not be right in CYDY land.
.
Good grief, did someone forget to carry the one?
PFE down a bit since market opened(I imagine some profit taking by day traders?). Still up over 4%.
Damn straight:
Ya, that was kind of my point, but you would think there would be some sort of correlation.
Cytodyn’s lawyers sent them a letter to take down report because of numerous misleading statements and an incredible amount of omissions , like they are presently in 2 FDA trials for Covid. They did. In the meantime, they along with Tim Sykes , who orchestrated the short attack , at 11:30 on Tuesday with his tweet , which then was followed by the Cintron report, all without any new news , have been reported to Finra and the SEC for stock manipulation.
Totally understand as they are not approved yet. But that is coming. Stock will be in $6-$12 range until the first Mild to moderate results are revealed and given to the FDA. They have deals with Samsung to manufacture and about to announce a distribution deal on Monday. They are getting ready for FDA approval. If approved for Covid , projected revenue by the end of the year will be 2.9 B and 9 B for 2021 for Covid use. But they have other indications , AIDS and Cancer to name 2 others that have a chance for approval before year end.
Not sure about you saying there are many more companies with better risk reward profiles based on market , since I highly doubt any of them have the low risk / high reward of Cydy. The reward is through the roof. Not many stocks like that especially in this crisis.
